Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Noe

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|June 20, 2025
[Encephalitis or schizophrenia as a cause of cognitive decline]Kristian Ørbæk Kirk, Christian Noe Weis
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|February 14, 2007
Diosgenin contents and DNA fingerprint screening of various yam (Dioscorea sp.) genotypesOliver Vendl, Christoph Wawrosch, Christian Noe, et al.
Artificial Organs|June 26, 2023
Dual lumen cannulation and mobilization of patients with venovenous extracorporeal membrane oxygenationChristian Noe, Felix A Rottmann, Xavier Bemtgen, et al.
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|November 26, 2009
Comparison of aragonitic molluscan shell proteinsTakeshi Furuhashi, Ivan Miksik, Miloslav Smrz, et al.
Frontiers in Medicine|October 16, 2023
Survival outcomes and mobilization during venovenous extracorporeal membrane oxygenation: a retrospective cohort studyFelix A Rottmann, Christian Noe, Xavier Bemtgen, et al.
Frontiers in Medicine|June 13, 2024
Corrigendum: Survival outcomes and mobilization during venovenous extracorporeal membrane oxygenation: a retrospective cohort studyFelix A Rottmann, Christian Noe, Xavier Bemtgen, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 12, 2004
Stereoselective synthesis and preliminary evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): identification of (+)-3-MATIDA as a novel mGluR1 competitive antagonistGabriele Costantino, Maura Marinozzi, Emidio Camaioni, et al.
Neuropharmacology|May 17, 2002
The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal deathFlavio Moroni, Sabina Attucci, Andrea Cozzi, et al.
Pharmacogenomics|March 21, 2025
Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic reviewMarlene Schouby Bentestuen, Christian Noe Weis, Caroline Bækmann Jeppesen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|June 20, 2025
[Encephalitis or schizophrenia as a cause of cognitive decline]Kristian Ørbæk Kirk, Christian Noe Weis
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|February 14, 2007
Diosgenin contents and DNA fingerprint screening of various yam (Dioscorea sp.) genotypesOliver Vendl, Christoph Wawrosch, Christian Noe, et al.
Artificial Organs|June 26, 2023
Dual lumen cannulation and mobilization of patients with venovenous extracorporeal membrane oxygenationChristian Noe, Felix A Rottmann, Xavier Bemtgen, et al.
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|November 26, 2009
Comparison of aragonitic molluscan shell proteinsTakeshi Furuhashi, Ivan Miksik, Miloslav Smrz, et al.
Frontiers in Medicine|October 16, 2023
Survival outcomes and mobilization during venovenous extracorporeal membrane oxygenation: a retrospective cohort studyFelix A Rottmann, Christian Noe, Xavier Bemtgen, et al.
Frontiers in Medicine|June 13, 2024
Corrigendum: Survival outcomes and mobilization during venovenous extracorporeal membrane oxygenation: a retrospective cohort studyFelix A Rottmann, Christian Noe, Xavier Bemtgen, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 12, 2004
Stereoselective synthesis and preliminary evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): identification of (+)-3-MATIDA as a novel mGluR1 competitive antagonistGabriele Costantino, Maura Marinozzi, Emidio Camaioni, et al.
Neuropharmacology|May 17, 2002
The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal deathFlavio Moroni, Sabina Attucci, Andrea Cozzi, et al.
Pharmacogenomics|March 21, 2025
Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic reviewMarlene Schouby Bentestuen, Christian Noe Weis, Caroline Bækmann Jeppesen, et al.
Pageof 1